Gimv : Mediar Therapeutics Announces Clinical Candidates for Lead Fibrosis Programs, Strategic Collaborations and Key Leadership Addition -October 25, 2023 at 10:58 am EDT
CAMBRIDGE, Mass., October 25, 2023 - Mediar Therapeutics Inc., a biotechnology company advancing a portfolio of first-in-class therapies that halt fibrosis progression, today announced several...
Source: marketscreener.com